guidance-registries — open questions

• Does a written eczema action plan reduce eczema severity (e.g. POEM/EASI) in children under 5, or only parent confidence? No toddler-specific RCT found.
• What do the 44-week TRuE-AD3 extension data show for long-term safety (blood counts, growth, infections) of ruxolitinib cream in 2–6-year-olds?
• Is there a validated UK (National Eczema Society or NHS) eczema action plan template, and has any been tested in primary care (e.g. the Bristol EWAP project)?